Patient Pathfinder: Clinical Trials
Clinical Trials for Chronic Lymphocytic Leukemia
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 176 active Chronic Lymphocytic Leukemia trials
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Study Type: Interventional Phase 1
Biomarker for Infection Risk in CLL and MM
Study Type: Observational
Allo HSCT Using RIC and PTCy for Hematological Diseases
Study Type: Interventional Phase 2
Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies
Study Type: Interventional Phase 1
Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax
Study Type: Observational
Tafasitamab and Zanubrutinib for the Treatment of Patients With Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, TaZA CLL Study
Study Type: Interventional Phase 2
Pirtobrutinib and Venetoclax Combined With Minimal Residual Disease Detection for Previously Untreated Chronic Lymphocytic Leukemia
Study Type: Interventional Phase 2
BR101801 in Adult Patients With Advanced Hematologic Malignancies( Phase I)
Study Type: Interventional Phase 1
There are 176 active Chronic Lymphocytic Leukemia trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now